Absci Corp logo

Absci Corp

ABSI
Healthcare|Biotechnology|USA
$10.60
-0.87 (-7.59%)
Tangible Book
$0.85

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 7.19, 22.22, 49.09, 55.77, 104.95 ], "ebit_estimate": [ -130.04, -121.28, -146.83, -164.41, -127.63 ], "ebitda_estimate": [ -109.74, -111.38, -86.62, -121.3, null ], "net_income_estimate": [ -123.28, -112.35, -153.22, -162.28, -118.79 ], "per_share_eps_estimate": [ -0.81, -0.66, -0.73, -0.68, -0.43 ], "eps_nri_estimate": [ -0.8, -0.68, -0.73, -0.68, -0.43 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 1.31, 1.38, 1.43, null, null ], "pretax_income_estimate": [ -127.89, -123.03, -144.31, -162.28, -118.79 ], "operating_cash_flow_per_share_estimate": [ -0.68, -0.6, null, null, null ], "roa_estimate": [ -57.1, -66.2, null, null, null ], "roe_estimate": [ -57.3, -58.78, -41.89, null, null ], "gross_margin_estimate": [ 100, 100, 100, 100, null ], "operating_cash_flow_estimate": [ -104.01, -91.78, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": 5.74, "long_term_revenue_growth_rate_mean": "164.34", "future_per_share_eps_estimate_growth": 6.12, "future_eps_nri_estimate_growth": 5.74, "future_revenue_estimate_growth": 164.34, "future_ebit_estimate_growth": -5.42, "future_ebitda_estimate_growth": 6.41, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -7.93, "future_pretax_income_estimate_growth": -6.6, "future_book_value_per_share_estimate_growth": 4.66, "future_roa_estimate_growth": null, "future_roe_estimate_growth": 11.08, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ 1.27, 1.35, 1.6, 1.7, 4.55, 4.5, 4.1, 1.7 ], "ebit_estimate": [ -32.22, -32.28, -34.04, -31.5, -31.5, -32, -32.5, null ], "ebitda_estimate": [ -29.65, -27.65, -30.45, -3.9, -29.9, -27.2, -23.4, -3 ], "net_income_estimate": [ -30.29, -30.85, -32.64, -30.5, -30.5, -31, -31.5, null ], "per_share_eps_estimate": [ -0.2, -0.21, -0.2, -0.2, -0.2, -0.2, -0.21, null ], "eps_nri_estimate": [ -0.2, -0.21, -0.2, -0.2, -0.2, -0.2, -0.21, null ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -31.37, -32.52, -34.09, -30.5, -30.5, -31, -31.5, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ 100, 100, 100, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null, null ], "long_term_growth_rate_mean": 5.74, "long_term_revenue_growth_rate_mean": "164.34", "future_per_share_eps_estimate_growth": 6.12, "future_eps_nri_estimate_growth": 5.74, "future_revenue_estimate_growth": 164.34, "future_ebit_estimate_growth": -5.42, "future_ebitda_estimate_growth": 6.41, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -7.93, "future_pretax_income_estimate_growth": -6.6, "future_book_value_per_share_estimate_growth": 4.66, "future_roa_estimate_growth": null, "future_roe_estimate_growth": 11.08, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-07-07 00:25:29
2026-07-06 13:00:08
2026-07-06 13:00:08
2026-07-02 13:33:04
2026-06-25 12:33:55
2026-06-24 20:30:31
2026-06-24 18:01:07
2026-06-24 11:59:54
2026-06-24 11:58:32
2026-06-24 11:26:54
2026-06-24 10:50:45
2026-06-16 13:02:02
2026-06-15 15:39:03